NCT05302492

Elderly Sleep Disturbance Through Home Care Solution

Completed NA Last updated 7 February 2024

What this trial tests

NA trial testing CPAP in Aging in 107 participants. Completed in 31 May 2023.

Timeline

17 May 2021

Primary endpoint
31 May 2023

31 May 2023

Quick facts

Lead sponsor	Chang Gung Memorial Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	107
Start date	17 May 2021
Primary completion	31 May 2023
Estimated completion	31 May 2023
Sites	1 location across Taiwan

Drugs / interventions tested

• CPAP
• Light box

Conditions studied

• Aging — all drugs for Aging →
• Sleep Disturbance — all drugs for Sleep Disturbance →

Sponsor

Chang Gung Memorial Hospital

Who can join

65 and older, any sex, with Aging or Sleep Disturbance. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Humans spend a third of their time on sleep. Therefore, maintaining a deep, stable and consistent sleep is very important for a good quality of life. Aging is often related to a decrease in the ability to fall asleep and maintain sleep. Getting older, various factors can worsen the normal sleep process, which is essential for restoring function and body function. Aging-related diseases, life changes, or own aging can disrupt the normal sleep cycle and seriously affect healthy aging. For example, the circadian rhythm and sleep consolidation will be broken with normal aging. These changes may lead to aging, or become part of the risk factors for diseases such as Alzheimer's disease. How to avoid disability and dementia by improving the quality of sleep to make the elderly healthy and aging, will bring huge effects to the economy, society, and health care.

From this plan, investigators will participate in an integrated plan (main plan)-" Integrating Systematic Data of Geriatric Medicine to Explore the Solution for Healthy Aging". In the main plan, 500 subjects will be enrolled. All subjects consent to provide medical record and will be tested for sarcopenia, including body composition, 4-meter walk, handgrip strength. The subjects screened sleep-affected subjects. It is estimated that 250 people will be invited for home sleep testing, such as continuous positive pressure breathing aid (CPAP) for sleep apnea (OSA) (approximately 120 subjects). For non-OSA and non-periodic limb movement disorder (PLMS) sleep problems, take a phototherapy program (about 60 subjects). The following goals are expected to be achieved:

1. Link to the main project to explore the correlation between common sleep disorders in the elderly and blood pressure, cognition, sarcopenia, metabolomics or intestinal microbiome
2. To verify the prognosis of sleep apnea and sleep disorders after intervention.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.